Evaluating the Feasibility of High-volume, Low-risk Penicillin Allergy De-labelling to Maximise Efficiency in a Resource-limited Setting

NANot yet recruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

October 31, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Penicillin Allergy
Interventions
DIAGNOSTIC_TEST

Single dose low-risk penicillin challenge

Initial screening to establish low risk allergy status followed by a single dose challenge using a standard penicillin dose. All challenges will be oral, conducted in a hospital setting and will be followed by a 1 hour monitoring period.

All Listed Sponsors
lead

University Hospital Southampton NHS Foundation Trust

OTHER

NCT06532448 - Evaluating the Feasibility of High-volume, Low-risk Penicillin Allergy De-labelling to Maximise Efficiency in a Resource-limited Setting | Biotech Hunter | Biotech Hunter